Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

The Transcriptionally Permissive Chromatin State of Embryonic Stem Cells Is Acutely Tuned to Translational Output.

Bulut-Karslioglu A, Macrae TA, Oses-Prieto JA, Covarrubias S, Percharde M, Ku G, Diaz A, McManus MT, Burlingame AL, Ramalho-Santos M.

Cell Stem Cell. 2018 Mar 1;22(3):369-383.e8. doi: 10.1016/j.stem.2018.02.004.

PMID:
29499153
2.

CRISPR-Cas9: a promising genetic engineering approach in cancer research.

Ratan ZA, Son YJ, Haidere MF, Uddin BMM, Yusuf MA, Zaman SB, Kim JH, Banu LA, Cho JY.

Ther Adv Med Oncol. 2018 Feb 5;10:1758834018755089. doi: 10.1177/1758834018755089. eCollection 2018. Review.

3.

Protein Structure and Biology: Poster Abstracts.

[No authors listed]

Prion. 2013 Apr/May;7(sup1):81-104. doi: 10.4161/pri.24866. No abstract available.

4.

CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery.

Luo J.

Trends Cancer. 2016 Jun;2(6):313-324. doi: 10.1016/j.trecan.2016.05.001. Review.

5.

TGFβ1-induced leucine limitation uncovered by differential ribosome codon reading.

Loayza-Puch F, Rooijers K, Zijlstra J, Moumbeini B, Zaal EA, Oude Vrielink JF, Lopes R, Ugalde AP, Berkers CR, Agami R.

EMBO Rep. 2017 Apr;18(4):549-557. doi: 10.15252/embr.201744000. Epub 2017 Mar 8.

6.

A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.

Park RJ, Wang T, Koundakjian D, Hultquist JF, Lamothe-Molina P, Monel B, Schumann K, Yu H, Krupzcak KM, Garcia-Beltran W, Piechocka-Trocha A, Krogan NJ, Marson A, Sabatini DM, Lander ES, Hacohen N, Walker BD.

Nat Genet. 2017 Feb;49(2):193-203. doi: 10.1038/ng.3741. Epub 2016 Dec 19.

7.

Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells.

Hess GT, Frésard L, Han K, Lee CH, Li A, Cimprich KA, Montgomery SB, Bassik MC.

Nat Methods. 2016 Dec;13(12):1036-1042. doi: 10.1038/nmeth.4038. Epub 2016 Oct 31.

8.

Genetic screens to study the immune system in cancer.

Wucherpfennig KW, Cartwright AN.

Curr Opin Immunol. 2016 Aug;41:55-61. doi: 10.1016/j.coi.2016.05.007. Epub 2016 Jun 13. Review.

9.

Genetic dissection of mammalian ERAD through comparative haploid and CRISPR forward genetic screens.

Timms RT, Menzies SA, Tchasovnikarova IA, Christensen LC, Williamson JC, Antrobus R, Dougan G, Ellgaard L, Lehner PJ.

Nat Commun. 2016 Jun 10;7:11786. doi: 10.1038/ncomms11786.

10.

Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification.

Deans RM, Morgens DW, Ökesli A, Pillay S, Horlbeck MA, Kampmann M, Gilbert LA, Li A, Mateo R, Smith M, Glenn JS, Carette JE, Khosla C, Bassik MC.

Nat Chem Biol. 2016 May;12(5):361-6. doi: 10.1038/nchembio.2050. Epub 2016 Mar 28.

11.

Quantitative evaluation of first, second, and third generation hairpin systems reveals the limit of mammalian vector-based RNAi.

Watanabe C, Cuellar TL, Haley B.

RNA Biol. 2016;13(1):25-33. doi: 10.1080/15476286.2015.1128062.

12.

HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.

Putcha P, Yu J, Rodriguez-Barrueco R, Saucedo-Cuevas L, Villagrasa P, Murga-Penas E, Quayle SN, Yang M, Castro V, Llobet-Navas D, Birnbaum D, Finetti P, Woodward WA, Bertucci F, Alpaugh ML, Califano A, Silva J.

Breast Cancer Res. 2015 Dec 8;17(1):149. doi: 10.1186/s13058-015-0658-0. Erratum in: Breast Cancer Res. 2017 Apr 19;19(1):49.

13.

Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.

Mockenhaupt S, Grosse S, Rupp D, Bartenschlager R, Grimm D.

Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4007-16. doi: 10.1073/pnas.1510476112. Epub 2015 Jul 13.

14.

Next-generation libraries for robust RNA interference-based genome-wide screens.

Kampmann M, Horlbeck MA, Chen Y, Tsai JC, Bassik MC, Gilbert LA, Villalta JE, Kwon SC, Chang H, Kim VN, Weissman JS.

Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3384-91. doi: 10.1073/pnas.1508821112. Epub 2015 Jun 15.

15.

Combined in vitro transcription and reverse transcription to amplify and label complex synthetic oligonucleotide probe libraries.

Murgha Y, Beliveau B, Semrau K, Schwartz D, Wu CT, Gulari E, Rouillard JM.

Biotechniques. 2015 Jun 1;58(6):301-7. doi: 10.2144/000114298. eCollection 2015 Jun.

16.

High-throughput functional genomics using CRISPR-Cas9.

Shalem O, Sanjana NE, Zhang F.

Nat Rev Genet. 2015 May;16(5):299-311. doi: 10.1038/nrg3899. Epub 2015 Apr 9. Review.

17.
18.

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.

Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M, Weissman JS.

Cell. 2014 Oct 23;159(3):647-61. doi: 10.1016/j.cell.2014.09.029. Epub 2014 Oct 9.

19.

Unraveling the mechanism of cell death induced by chemical fibrils.

Julien O, Kampmann M, Bassik MC, Zorn JA, Venditto VJ, Shimbo K, Agard NJ, Shimada K, Rheingold AL, Stockwell BR, Weissman JS, Wells JA.

Nat Chem Biol. 2014 Nov;10(11):969-76. doi: 10.1038/nchembio.1639. Epub 2014 Sep 28.

20.

RNAi screening comes of age: improved techniques and complementary approaches.

Mohr SE, Smith JA, Shamu CE, Neumüller RA, Perrimon N.

Nat Rev Mol Cell Biol. 2014 Sep;15(9):591-600. doi: 10.1038/nrm3860. Review.

Supplemental Content

Support Center